戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 r 133Xe SPECT, subjects received 22 +/- 4mCi 99mTc-HMPAO, and images were acquired 15 min after injec
2 -ECD: sensitivity = 100%, specificity = 92%; 99mTc-HMPAO: sensitivity = 100%, specificity = 85%).
3                                            A 99mTc-HMPAO brain SPECT showed diminished perfusion in t
4 ning began on average 11.5 +/- 2.8 min after 99mTc-HMPAO injection and 41.8 +/- 10.1 min after 99mTc-
5 rinogen (0.18 +/- 0.02% ID/g) (p < 0.05) and 99mTc-HMPAO-platelets (0.14 +/- 0.02% ID/g, p < 0.05).
6 n of distribution (ratios) between 133Xe and 99mTc-HMPAO (r = 0.66).
7                Comparisons between 133Xe and 99mTc-HMPAO were evaluated using a Bonferroni-corrected
8 ch between 99mTc-MIBI (increased uptake) and 99mTc-HMPAO (absent uptake) brain SPECT images.
9 ith symmetric cerebral perfusion measured by 99mTc-HMPAO SPECT may still have a high long-term compli
10                          This study compares 99mTc-HMPAO count ratios and derived regional cerebral b
11 min/100 g, 133Xe) or regional count density (99mTc-HMPAO) were extracted from 24 ROI located 6 cm abo
12  comparison between rCBF (133Xe) and derived 99mTc-HMPAO rCBF.
13 r 133Xe or to global count density (gCD) for 99mTc-HMPAO.
14 esearch aimed to compare cerebral images for 99mTc-HMPAO and 99mTc-ECD in discriminating patients wit
15 n the BNT correlated with low frontotemporal 99mTc-HMPAO (Spearman r = 0.97, P = 0.004) in the 5 pati
16            Brain SPECT showed a reduction in 99mTc-HMPAO uptake involving the frontal and temporal lo
17              Neuroimaging studies, including 99mTc-HMPAO brain SPECT, CT, and MRI, were performed.
18 aged up to 3 hours after injection of 10-mCi 99mTc-HMPAO-labeled autologous leukocytes (Tc-WBC), and
19                          The distribution of 99mTc-HMPAO is linearly related to rCBF measured by 133X
20 given intravenously 3 min before infusion of 99mTc-HMPAO.
21 n all other disintegrins, 125I-fibrinogen or 99mTc-HMPAO-platelets (p < 0.05).
22 , 99mTc-D,L-hexamethylpropylene amine oxide (99mTc-HMPAO, or exametazime) or 99mTc-ethylene-dicystein
23 racer, 99mTc-hexamethylpropyleneamine oxime (99mTc-HMPAO).
24 CBF ratios (133Xe) and count density ratios (99mTc-HMPAO).
25 was performed in 35 individuals who received 99mTc-HMPAO and in 55 who received 99mTc-ECD.
26 nvestigated the relationship between reduced 99mTc-HMPAO uptake and the severity of dysnomia in PPA.
27 chnetium-99m-ECD shows greater contrast than 99mTc-HMPAO between affected and unaffected brain struct
28      Technetium-99m-MIBI images, rather than 99mTc-HMPAO brain SPECT, resulted in the correct patholo
29 etween AD patients and control subjects than 99mTc-HMPAO.
30  133Xe SPECT, although our data suggest that 99mTc-HMPAO mildly underestimates rCBF above 80 ml/min/1
31 pus and small areas of the cerebellum in the 99mTc-HMPAO group as compared to the 99mTc-ECD group.
32 ral cortices were significantly lower in the 99mTc-HMPAO group than in the 99mTc-ECD group.
33 nding to the motor cortices was noted on the 99mTc-HMPAO SPECT scan obtained in the acute phase.
34                           Patients underwent 99mTc-HMPAO brain SPECT with transmission line source AC
35    Each patient underwent a SPECT scan using 99mTc-HMPAO at rest.
36 bjective of this study was to assess whether 99mTc-HMPAO brain SPECT imaging can identify patients at
37                      Leukocytes labeled with 99mTc-HMPAO and 111In have been used extensively in imag
38  subjects underwent a brain SPECT study with 99mTc-HMPAO.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。